Ketamine
Book Details
Format
Paperback / Softback
Book Series
MIT Press Essential Knowledge
ISBN-10
0262542242
ISBN-13
9780262542241
Publisher
MIT Press Ltd
Imprint
MIT Press
Country of Manufacture
US
Country of Publication
GB
Publication Date
Feb 16th, 2021
Print length
136 Pages
Weight
198 grams
Dimensions
12.80 x 17.70 x 1.90 cms
Product Classification:
Psychology
Ksh 2,900.00
Werezi Extended Catalogue
Delivery in 14 days
2 copies in stock
Delivery Location
Delivery fee: Select location
Delivery in 14 days
Secure
Quality
Fast
The emergence of ketamine--previously known as a combat anesthetic and club drug--as a treatment for depression. Ketamine, approved in 2019 by the Food and Drug Administration for the treatment of depression, has been touted by scientists and media reports as something approaching a miracle cure. This volume in the MIT Press Essential Knowledge series chronicles the ascent of a drug that has been around for fifty years--in previous incarnations, a Vietnam-era combat anesthetic and a popular club drug--that has now been reinvented as a treatment for depression. Bita Moghaddam, a leading researcher in neuropharmacology, explains the scientific history and the biology of ketamine, its clinical use, and its recently discovered antidepressant effects, for the nonspecialist reader.
The emergence of ketamine--previously known as a combat anesthetic and club drug--as a treatment for depression.
Ketamine, approved in 2019 by the Food and Drug Administration for the treatment of depression, has been touted by scientists and media reports as something approaching a miracle cure. This volume in the MIT Press Essential Knowledge series chronicles the ascent of a drug that has been around for fifty years--in previous incarnations, a Vietnam-era combat anesthetic and a popular club drug--that has now been reinvented as a treatment for depression. Bita Moghaddam, a leading researcher in neuropharmacology, explains the scientific history and the biology of ketamine, its clinical use, and its recently discovered antidepressant effects, for the nonspecialist reader.
Ketamine, approved in 2019 by the Food and Drug Administration for the treatment of depression, has been touted by scientists and media reports as something approaching a miracle cure. This volume in the MIT Press Essential Knowledge series chronicles the ascent of a drug that has been around for fifty years--in previous incarnations, a Vietnam-era combat anesthetic and a popular club drug--that has now been reinvented as a treatment for depression. Bita Moghaddam, a leading researcher in neuropharmacology, explains the scientific history and the biology of ketamine, its clinical use, and its recently discovered antidepressant effects, for the nonspecialist reader.
Get Ketamine by at the best price and quality guaranteed only at Werezi Africa's largest book ecommerce store. The book was published by MIT Press Ltd and it has pages.